Skip to content
Disclosery

EXANE DERIVATIVES: LEN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on LEN, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 27 LEN shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 27 shares
    Change vs previous 13F -713 shares

    <0.01% of the 13F portfolio, value $1,905.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 740 shares
    Change vs previous 13F -257 shares

    0.02% of the 13F portfolio, value $60,065.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 997 shares
    Change vs previous 13F +644 shares

    0.03% of the 13F portfolio, value $115,813.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 353 shares
    Change vs previous 13F -4,568 shares

    0.01% of the 13F portfolio, value $33,070.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,921 shares
    Change vs previous 13F +3,883 shares

    0.11% of the 13F portfolio, value $471,435.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 1,038 shares
    Change vs previous 13F -159 shares

    0.03% of the 13F portfolio, value $105,078.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,197 shares
    Change vs previous 13F -12,589 shares

    0.03% of the 13F portfolio, value $91,249.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 13,786 shares
    Change vs previous 13F not available

    0.37% of the 13F portfolio, value $1,126,035.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).